title: Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.
abstract: Inactivation of the p53 gene is a common early event of astrocytoma tumorigenesis. Alternatively, since the p16, retinoblastoma (RB), and CDK4 genes have been implicated in malignant progression, detection of losses or amplifications of these genes in gliomas could be diagnostically, prognostically, and therapeutically important. We obtained smear preparations from 96 diffuse gliomas and 10 nonneoplastic specimens. Dual-color fluorescence in situ hybridizations using paired probes for CEN9/p16, CEN8/RB, CEN17/p53, and CEN12/CDK4 were performed and revealed expected frequencies of abnormalities, except for p53 losses, which were low (7%). The latter supports the concept that p53 inactivation usually occurs by mitotic recombination. Detected abnormalities of the p16/RB/CDK4 pathway were highly associated with astrocytic differentiation and were univariately associated with decreased patient survival. However, only patient age and histologic classification retained statistical significance on multivariate analysis. We conclude that in diffuse gliomas, p16/RB/CDK4 abnormalities are markers of astrocytic phenotype. Thus, their detection by fluorescence in situ hybridization may have diagnostic usefulness in cases with equivocal morphologic features. Although our numbers are small, we find no additional prognostic significance to these genetic abnormalities one age, grade, and oligodendroglial histology are taken into account.
authors.affiliation: Division of Neuropathology, Washington University, St Louis, Missouri, USA.
authors.forename: A
authors.initials: A
authors.lastname: Perry
authors.forename: K
authors.initials: K
authors.lastname: Anderl
authors.forename: T J
authors.initials: TJ
authors.lastname: Borell
authors.forename: D W
authors.initials: DW
authors.lastname: Kimmel
authors.forename: C H
authors.initials: CH
authors.lastname: Wang
authors.forename: J R
authors.initials: JR
authors.lastname: O'Fallon
authors.forename: B G
authors.initials: BG
authors.lastname: Feuerstein
authors.forename: B W
authors.initials: BW
authors.lastname: Scheithauer
authors.forename: R B
authors.initials: RB
authors.lastname: Jenkins
mesh_terms: D000328:Adult; D001253:Astrocytes / Q000473:pathology; D002454:Cell Differentiation; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics*; D018844:Cyclin-Dependent Kinases / Q000235:genetics*; D005260:Female; D017353:Gene Deletion; D016161:Genes, Retinoblastoma / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D005910:Glioma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009836:Oligodendroglia / Q000473:pathology; D011518:Proto-Oncogene Proteins; D015996:Survival Rate
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D011518:Proto-Oncogene Proteins; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases